AI In Clinical Trials Market Report 2026
AI In Clinical Trials Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

AI In Clinical Trials Market Report 2026

Global Outlook – By Offering (Software, Services), By Process (Trial Design, Patient Selection, Site Selection, Patient Monitoring), By Technology (Machine Learning, Deep Learning, Supervised Learning, Other Technologies), By Application (Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications), By End-User (Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

AI In Clinical Trials Market Overview

• AI In Clinical Trials market size has reached to $9.16 billion in 2025

• Expected to grow to $54.71 billion in 2030 at a compound annual growth rate (CAGR) of 43%

• Growth Driver: AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases

• Market Trend: Strategic Partnerships Harness AI To Accelerate Patient Recruitment And Enhance Workflow Efficiencies

North America was the largest region in 2025.

What Is Covered Under AI In Clinical Trials Market?

AI in clinical trials refers to the application of artificial intelligence (AI) technologies and techniques in the planning, design, execution, and analysis of clinical trials. Clinical trials are rigorous research studies that evaluate the safety and effectiveness of medical interventions, such as new drugs, medical devices, or treatment protocols, in human subjects.

The main offerings for AI in clinical trials are software and services. AI in clinical trial services refers to the services that are used to investigate and generate insight from past and current clinical trials. The various processes include trial design, patient selection, site selection, and patient monitoring with various technologies such as machine learning, deep learning, supervised learning, other machine learning technologies, and others. These are applied in various applications such as oncology, neurological diseases and condition, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases, and are used by various end-users such as pharmaceuticals and biotechnology companies, contract research organizations, and others.

AI In Clinical Trials market report bar graph

What Is The AI In Clinical Trials Market Size and Share 2026?

The AI in clinical trials market size has grown exponentially in recent years. It will grow from $9.16 billion in 2025 to $13.08 billion in 2026 at a compound annual growth rate (CAGR) of 42.8%. The growth in the historic period can be attributed to rising clinical trial complexity, increasing R&D expenditure, demand for faster drug development, growth in clinical data volumes, limitations of traditional trial methods.

What Is The AI In Clinical Trials Market Growth Forecast?

The AI in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $54.71 billion in 2030 at a compound annual growth rate (CAGR) of 43.0%. The growth in the forecast period can be attributed to expansion of decentralized clinical trials, increasing adoption of real world evidence, growth of precision medicine, rising regulatory acceptance of AI tools, advancements in healthcare analytics. Major trends in the forecast period include AI driven patient recruitment, predictive trial outcome modeling, automated clinical data analysis, remote patient monitoring integration, adaptive trial design adoption.

Customer representative image Book your 30 minutes free consultation with our research experts

Global AI In Clinical Trials Market Segmentation

1) By Offering: Software, Services

2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring

3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies

4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications

5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users

Subsegments:

1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms

2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services

What Is The Driver Of The AI In Clinical Trials Market?

Rising incidences of chronic and infectious diseases are expected to propel the growth of the AI in clinical trials market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Artificial intelligence in clinical trials is helpful to develop various drugs for treating chronic diseases. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, reported that in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising incidences of chronic and infectious diseases are driving the growth of the AI in the clinical trials market.

Key Players In The Global AI In Clinical Trials Market

Major companies operating in the AI in clinical trials market are ConcertAI Inc.; Owkin Inc.; AiCure Technologies Inc.; Ardigen S.A.; Unlearn.AI Inc.; PathAI Inc.; Exscientia plc; VeriSIM Life Inc.; Envisagenics Inc.; NURITAS Limited; BioSymetrics Inc.; Trials.AI Inc.; IQVIA Holdings Inc.; Euretos B.V.; Saama Technologies LLC; Deep 6 AI Inc.; Medidata Solutions Inc.; Antidote Technologies Inc.; Castor EDC B.V.; TrialSpark Inc.; Phesi S.A.; CluePoints NV

Global AI In Clinical Trials Market Trends and Insights

Major companies operating in the AI in clinical trials market are adopting a strategic partnership approach to deliver research tools and workflow efficiencies that result in improved timelines and increased patient recruitment. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in February 2023, a US-based pharmaceutical commercial company partnered with Haystack Health, a US-based software development company. With this partnership, they aim to leverage AI and Natural Language Processing (NLP) to speed up clinical trials, improve patient recruitment, and reduce the screen failure rate through the use of clinical AI and pre-screening services, which can be costly in terms of time and money.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The AI In Clinical Trials Market?

In April 2024, Clario, a US-based provider of data-solutions and clinical trial technology company, acquired ArtiQ for an undisclosed amount. With this acquisition, Clario aims to enhance its artificial intelligence-driven respiratory solutions and strengthen its overall AI/ML capability across clinical trial endpoints. ArtiQ is a Belgium-based provider of AI-powered software that supports diagnosis, monitoring and optimization of respiratory clinical trials through advanced machine-learning models.

Regional Insights

North America was the largest region in the AI in clinical trials market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Clinical Trials Market?

The AI in clinical trials market consists of revenues earned by entities by providing AI software solutions and platforms designed to assist in various aspects of clinical trials, such as trial design, patient recruitment, data collection, monitoring, and analysis, data analytics and insights, predictive modeling and simulation, regulatory compliance, and safety monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in clinical trials also includes sales of computer vision technology, cognitive computing, and machine translation technologies which are used in providing clinical trials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Clinical Trials Market Report 2026?

The ai in clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

AI In Clinical Trials Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $13.08 billion
Revenue Forecast In 2035 $54.71 billion
Growth Rate CAGR of 42.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Offering, Process, Technology, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled ConcertAI Inc.; Owkin Inc.; AiCure Technologies Inc.; Ardigen S.A.; Unlearn.AI Inc.; PathAI Inc.; Exscientia plc; VeriSIM Life Inc.; Envisagenics Inc.; NURITAS Limited; BioSymetrics Inc.; Trials.AI Inc.; IQVIA Holdings Inc.; Euretos B.V.; Saama Technologies LLC; Deep 6 AI Inc.; Medidata Solutions Inc.; Antidote Technologies Inc.; Castor EDC B.V.; TrialSpark Inc.; Phesi S.A.; CluePoints NV
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. AI In Clinical Trials Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global AI In Clinical Trials Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. AI In Clinical Trials Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global AI In Clinical Trials Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 AI Driven Patient Recruitment

4.2.2 Predictive Trial Outcome Modeling

4.2.3 Automated Clinical Data Analysis

4.2.4 Remote Patient Monitoring Integration

4.2.5 Adaptive Trial Design Adoption

5. AI In Clinical Trials Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies

5.2 Biotechnology Companies

5.3 Contract Research Organizations

5.4 Academic Research Institutes

5.5 Healthcare Research Centers

6. AI In Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global AI In Clinical Trials Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global AI In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global AI In Clinical Trials Market Size, Comparisons And Growth Rate Analysis

7.3. Global AI In Clinical Trials Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global AI In Clinical Trials Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global AI In Clinical Trials Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. AI In Clinical Trials Market Segmentation

9.1. Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Software, Services

9.2. Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Trial Design, Patient Selection, Site Selection, Patient Monitoring

9.3. Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Machine Learning, Deep Learning, Supervised Learning, Other Technologies

9.4. Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications

9.5. Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users

9.6. Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms

9.7. Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services

10. AI In Clinical Trials Market, Industry Metrics By Country

10.1. Global AI In Clinical Trials Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

10.2. Global AI In Clinical Trials Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. AI In Clinical Trials Market Regional And Country Analysis

11.1. Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11.2. Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific AI In Clinical Trials Market

12.1. Asia-Pacific AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. Asia-Pacific AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China AI In Clinical Trials Market

13.1. China AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. China AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India AI In Clinical Trials Market

14.1. India AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan AI In Clinical Trials Market

15.1. Japan AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

15.2. Japan AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia AI In Clinical Trials Market

16.1. Australia AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia AI In Clinical Trials Market

17.1. Indonesia AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea AI In Clinical Trials Market

18.1. South Korea AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. South Korea AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan AI In Clinical Trials Market

19.1. Taiwan AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. Taiwan AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia AI In Clinical Trials Market

20.1. South East Asia AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. South East Asia AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe AI In Clinical Trials Market

21.1. Western Europe AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

21.2. Western Europe AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK AI In Clinical Trials Market

22.1. UK AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany AI In Clinical Trials Market

23.1. Germany AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France AI In Clinical Trials Market

24.1. France AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy AI In Clinical Trials Market

25.1. Italy AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain AI In Clinical Trials Market

26.1. Spain AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe AI In Clinical Trials Market

27.1. Eastern Europe AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

27.2. Eastern Europe AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia AI In Clinical Trials Market

28.1. Russia AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America AI In Clinical Trials Market

29.1. North America AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. North America AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA AI In Clinical Trials Market

30.1. USA AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. USA AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada AI In Clinical Trials Market

31.1. Canada AI In Clinical Trials Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. Canada AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America AI In Clinical Trials Market

32.1. South America AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

32.2. South America AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil AI In Clinical Trials Market

33.1. Brazil AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East AI In Clinical Trials Market

34.1. Middle East AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Middle East AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa AI In Clinical Trials Market

35.1. Africa AI In Clinical Trials Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

35.2. Africa AI In Clinical Trials Market, Segmentation By Offering, Segmentation By Process, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. AI In Clinical Trials Market Regulatory and Investment Landscape

37. AI In Clinical Trials Market Competitive Landscape And Company Profiles

37.1. AI In Clinical Trials Market Competitive Landscape And Market Share 2024

37.1.1. Top 10 Companies (Ranked by revenue/share)

37.2. AI In Clinical Trials Market - Company Scoring Matrix

37.2.1. Market Revenues

37.2.2. Product Innovation Score

37.2.3. Brand Recognition

37.3. AI In Clinical Trials Market Company Profiles

37.3.1. ConcertAI Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.2. Owkin Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.3. AiCure Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37.3.4. Ardigen S.A. Overview, Products and Services, Strategy and Financial Analysis

37.3.5. Unlearn.AI Inc. Overview, Products and Services, Strategy and Financial Analysis

38. AI In Clinical Trials Market Other Major And Innovative Companies

PathAI Inc., Exscientia plc, VeriSIM Life Inc., Envisagenics Inc., NURITAS Limited, BioSymetrics Inc., Trials.AI Inc., IQVIA Holdings Inc., Euretos B.V., Saama Technologies LLC, Deep 6 AI Inc., Medidata Solutions Inc., Antidote Technologies Inc., Castor EDC B.V., TrialSpark Inc.

39. Global AI In Clinical Trials Market Competitive Benchmarking And Dashboard

40. Key Mergers And Acquisitions In The AI In Clinical Trials Market

41. AI In Clinical Trials Market High Potential Countries, Segments and Strategies

41.1. AI In Clinical Trials Market In 2030 - Countries Offering Most New Opportunities

41.2. AI In Clinical Trials Market In 2030 - Segments Offering Most New Opportunities

41.3. AI In Clinical Trials Market In 2030 - Growth Strategies

41.3.1. Market Trend Based Strategies

41.3.2. Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global AI In Clinical Trials Market, Overview Of Key Products - Product Examples
  • Table 2: Global AI In Clinical Trials Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global AI In Clinical Trials Market, Supply Chain Analysis
  • Table 4: Global AI In Clinical Trials Market, Major Raw Material Providers
  • Table 5: Global AI In Clinical Trials Market, Major Resource Providers
  • Table 6: Global AI In Clinical Trials Market, Major Manufacturers (Suppliers)
  • Table 7: Global AI In Clinical Trials Market, Major Distributors And Channel Partners
  • Table 8: Global AI In Clinical Trials Market, Key Technologies & Future Trends
  • Table 9: Global AI In Clinical Trials Market, Major Trends
  • Table 10: Global AI In Clinical Trials Market, Major End Users
  • Table 11: Global AI In Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global AI In Clinical Trials Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global AI In Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global AI In Clinical Trials Market - TAM, US$ Billion, 2025
  • Table 15: Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global AI In Clinical Trials Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 23: Global AI In Clinical Trials Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Table 24: Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global AI In Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global AI In Clinical Trials Market - Company Scoring Matrix
  • Table 100: ConcertAI Inc. Financial Performance
  • Table 101: Owkin Inc. Financial Performance
  • Table 102: AiCure Technologies Inc. Financial Performance
  • Table 103: Ardigen S.A. Financial Performance
  • Table 104: Unlearn.AI Inc. Financial Performance
  • Table 105: Global AI In Clinical Trials Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global AI In Clinical Trials Market, Competitive Dashboard
  • Table 107: Global AI In Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Table 109: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030
  • Table 110: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

    Figure 1: Global AI In Clinical Trials Market, Overview Of Key Products - Product Examples
  • Figure 2: Global AI In Clinical Trials Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global AI In Clinical Trials Market, Supply Chain Analysis
  • Figure 4: Global AI In Clinical Trials Market, Major Raw Material Providers
  • Figure 5: Global AI In Clinical Trials Market, Major Resource Providers
  • Figure 6: Global AI In Clinical Trials Market, Major Manufacturers (Suppliers)
  • Figure 7: Global AI In Clinical Trials Market, Major Distributors And Channel Partners
  • Figure 8: Global AI In Clinical Trials Market, Key Technologies & Future Trends
  • Figure 9: Global AI In Clinical Trials Market, Major Trends
  • Figure 10: Global AI In Clinical Trials Market, Major End Users
  • Figure 11: Global AI In Clinical Trials Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global AI In Clinical Trials Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global AI In Clinical Trials Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global AI In Clinical Trials Market - TAM, US$ Billion, 2025
  • Figure 15: Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global AI In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global AI In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global AI In Clinical Trials Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 23: Global AI In Clinical Trials Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • Figure 24: Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global AI In Clinical Trials Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global AI In Clinical Trials Market - Company Scoring Matrix
  • Figure 100: ConcertAI Inc. Financial Performance
  • Figure 101: Owkin Inc. Financial Performance
  • Figure 102: AiCure Technologies Inc. Financial Performance
  • Figure 103: Ardigen S.A. Financial Performance
  • Figure 104: Unlearn.AI Inc. Financial Performance
  • Figure 105: Global AI In Clinical Trials Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global AI In Clinical Trials Market, Competitive Dashboard
  • Figure 107: Global AI In Clinical Trials Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Offering, 2025 – 2030
  • Figure 109: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Process, 2025 – 2030
  • Figure 110: Global, AI In Clinical Trials Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Frequently Asked Questions

The AI In Clinical Trials Market Report 2026 market was valued at $9.16 billion in 2025, increased to $13.08 billion in 2026, and is projected to reach $54.71 billion by 2030. request a sample here

The expected CAGR for the AI In Clinical Trials Market Report 2026 market during the forecast period 2025–2030 is 43.0%. request a sample here

Major growth driver of the market includes: AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases in the AI In Clinical Trials Market Report 2026 market. For further insights on this market, request a sample here

The AI in clinical trials market covered in this report is segmented –
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
request a sample here

Major trend in this market includes: Strategic Partnerships Harness AI To Accelerate Patient Recruitment And Enhance Workflow Efficiencies For further insights on this market, request a sample here.

Major companies operating in the AI In Clinical Trials Market Report 2026 market are Major companies operating in the AI in clinical trials market are ConcertAI Inc.; Owkin Inc.; AiCure Technologies Inc.; Ardigen S.A.; Unlearn.AI Inc.; PathAI Inc.; Exscientia plc; VeriSIM Life Inc.; Envisagenics Inc.; NURITAS Limited; BioSymetrics Inc.; Trials.AI Inc.; IQVIA Holdings Inc.; Euretos B.V.; Saama Technologies LLC; Deep 6 AI Inc.; Medidata Solutions Inc.; Antidote Technologies Inc.; Castor EDC B.V.; TrialSpark Inc.; Phesi S.A.; CluePoints NV request a sample here.

North America was the largest region in the AI in clinical trials market in 2025. The regions covered in the AI in clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts